Connection
Daniel Sherbenou to Phosphotyrosine
This is a "connection" page, showing publications Daniel Sherbenou has written about Phosphotyrosine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.017 |
|
|
|
-
O'Hare T, Walters DK, Stoffregen EP, Sherbenou DW, Heinrich MC, Deininger MW, Druker BJ. Combined Abl inhibitor therapy for minimizing drug resistance in chronic myeloid leukemia: Src/Abl inhibitors are compatible with imatinib. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6987-93.
Score: 0.017